Cisen Pharmaceutical Co (SHSE:603367) Cyclically Adjusted FCF per Share: ¥0.78 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603367 Cisen Pharmaceutical Co Ltd SHSE:603367
68 GF Score
Price ¥14.90
GF Value ¥14.45
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Cisen Pharmaceutical Co Cyclically Adjusted FCF per Share?

Cisen Pharmaceutical Co SHSE:603367 -0.67% 68 Cyclically Adjusted FCF per Share is ¥0.78 as of Jun. 2026. GuruFocus rates SHSE:603367 with a GF Score™ of 68/100 and a GF Value™ of ¥14.45 (Fairly Valued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Cisen Pharmaceutical Co's adjusted free cash flow per share for the three months ended in Jun. 2026 was ¥0.491. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥0.78 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Cisen Pharmaceutical Co's average Cyclically Adjusted FCF Growth Rate was 5.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-09-02), Cisen Pharmaceutical Co's current stock price is ¥14.90. Cisen Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was ¥0.78. Cisen Pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is 19.10.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Cisen Pharmaceutical Co was 45.61. The lowest was 16.60. And the median was 20.89.


Cisen Pharmaceutical Co  (SHSE:603367) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Cisen Pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=14.90/0.78
=19.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Cisen Pharmaceutical Co was 45.61. The lowest was 16.60. And the median was 20.89.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Cisen Pharmaceutical Co Cyclically Adjusted FCF per Share Related Terms


Cisen Pharmaceutical Co Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Cisen Pharmaceutical Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cisen Pharmaceutical Co Cyclically Adjusted FCF per Share Chart

Cisen Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.70 0.73

Cisen Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.74 0.77 0.73 0.75 0.78

SHSE:603367 vs ZTS: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cisen Pharmaceutical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cisen Pharmaceutical Co Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cisen Pharmaceutical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Cisen Pharmaceutical Co's Cyclically Adjusted Price-to-FCF falls into.


SHSE:603367
68GF Score
Cisen Pharmaceutical Co Ltd SHSE:603367
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cisen Pharmaceutical Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cisen Pharmaceutical Co's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.491/116.0564*116.0564
=0.491

Current CPI (Jun. 2026) = 116.0564.

Cisen Pharmaceutical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 0.000 102.400 0.000
201612 0.000 102.600 0.000
201703 0.296 103.200 0.333
201706 0.050 103.100 0.056
201709 0.355 104.100 0.396
201712 0.351 104.500 0.390
201803 0.172 105.300 0.190
201806 -0.007 104.900 -0.008
201809 0.336 106.600 0.366
201812 0.301 106.500 0.328
201903 -0.026 107.700 -0.028
201906 0.231 107.700 0.249
201909 0.410 109.800 0.433
201912 -0.445 111.200 -0.464
202003 0.035 112.300 0.036
202006 0.064 110.400 0.067
202009 0.389 111.700 0.404
202012 0.016 111.500 0.017
202103 -0.077 112.662 -0.079
202106 0.120 111.769 0.125
202109 -0.053 112.215 -0.055
202112 0.416 113.108 0.427
202203 0.048 114.335 0.049
202206 0.088 114.558 0.089
202209 0.273 115.339 0.275
202212 0.074 115.116 0.075
202303 0.204 115.116 0.206
202306 0.230 114.558 0.233
202309 0.332 115.339 0.334
202312 0.190 114.781 0.192
202403 0.479 115.227 0.482
202406 -0.210 114.781 -0.212
202409 0.347 115.785 0.348
202412 0.409 114.893 0.413
202503 0.096 115.116 0.097
202506 0.564 114.907 0.570
202509 0.463 115.471 0.465
202512 -0.249 115.832 -0.249
202603 0.399 116.303 0.398
202606 0.491 116.056 0.491

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of ¥0.78 mean?
Cisen Pharmaceutical Co (SHSE:603367) has a Cyclically Adjusted FCF per Share of ¥0.78 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Cisen Pharmaceutical Co and its competitors.
Is Cisen Pharmaceutical Co's Cyclically Adjusted FCF per Share too high?
Cisen Pharmaceutical Co's current Cyclically Adjusted FCF per Share is ¥0.78. Overall, Cisen Pharmaceutical Co has a GF Score™ of 68/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cisen Pharmaceutical Co's Cyclically Adjusted FCF per Share compare to ZTS?
Cisen Pharmaceutical Co's Cyclically Adjusted FCF per Share of ¥0.78 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Cisen Pharmaceutical Co and its competitors. Cisen Pharmaceutical Co's current Cyclically Adjusted FCF per Share is ¥0.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cisen Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Cisen Pharmaceutical Co (SHSE:603367) is currently considered Fairly Valued. The stock's GF Value™ is ¥14.45, compared to a current price of ¥14.90 — trading 3.1% above its estimated fair value. The current Cyclically Adjusted FCF per Share is ¥0.78. Cisen Pharmaceutical Co's overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Cisen Pharmaceutical Co (SHSE:603367), the current Cyclically Adjusted FCF per Share is ¥0.78 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cisen Pharmaceutical Co (SHSE:603367) Overvalued in 2026?

Based on GuruFocus' analysis, Cisen Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥14.90 is trading 3.1% above its estimated GF Value™ of ¥14.45. GuruFocus considers Cisen Pharmaceutical Co to be Fairly Valued.

Key valuation signals for SHSE:603367:

  • Cyclically Adjusted FCF per Share: ¥0.78
  • GF Value™: ¥14.45 vs. price of ¥14.90 (3.1% above fair value)
  • GF Score™: 68/100 with 3 warning signs

No single metric tells the full story. See the SHSE:603367 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cisen Pharmaceutical Co Business Description

Address Tongji Sci-tech Industrial Park, High-tech Industrial Development Zone, Shandong, Jining, CHN, 272073
Cisen Pharmaceutical Co Ltd is the pharmaceutical company in China. The company's main business is the development, production and sales of pharmaceutical products, mainly in the production of chemical preparations. Its product offering includes chemical drug preparations such as liver disease drug, antitumor and auxiliary drugs, nutrition preparation, cardiovascular class, antibiotics, sedation anaesthesia snooze, digestive system agents; and healthcare products.
68GF Score

Get the complete analysis for SHSE:603367

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥14.90
Price
¥14.45
GF Value